Categories U.S. Markets News

FDA adds restrictions on sale of e-cigarettes

The US Food and Drug Administration (FDA) is bringing new restrictions to the sale of e-cigarettes to put an end to the “alarming” increase in vaping among teenagers. According to data collected by the agency, there was a 78% increase in vaping among high school students and a 48% increase among middle school students.

Sale of flavored e-cigarettes, except menthol, will be banned at places where the under-aged can purchase them. According to the FDA data, over 3.6 million school students currently use e-cigarettes.

e-cigarette restriction FDA
Courtesy: Wikimedia Commons

The move comes two months after the FDA Commissioner Scott Gottlieb tasked the cigarette makers to come up with an action plan to reduce addiction among teenagers. Altria (MO), British American Tobacco, Imperial Brands, and Japan Tobacco were asked to submit reports on the same before November 11.

Gottlieb has also set certain policies for the sale of these products, which, if violated, may lead to the products being pulled out of stores.

Altria shares were down 1.9% during intra-day trading following the announcement. Meanwhile, peer tobacco company Philip Morris International (PM) was almost flat on Thursday. Both companies have been hit hard by the crackdown on cigarette consumption by the FDA. During the past 52 weeks, Altria shares have been down 10.7%, while PM is down 16%.

Manufacturers who wish to sell flavored e-cigarettes in the future will now need to get it tested and authorized by the FDA. Gottlieb added that the products that are currently available in the market will also see a round of testing.

Altria was the first to respond to FDA’s latest requirements. The company said it would remove MarkTen pod-based products and would stop selling flavored products.

 

Get access to timely and accurate verbatim transcripts that are published within hours of the event

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top